ZBH financials
Zimmer Biomet Holdings, Inc. · end-of-day data as of Oct 16, 2026
Zimmer Biomet Holdings, Inc.
$94.98+4.2%
Hold · 28 analystsPT $103.48 +9.0%
ZBH reported revenue of $2.18B for the quarter ended Jun 30, 2026 (Q2 FY2026), up 4.8% from a year earlier. It posted diluted EPS of $1.03, free cash flow of $331M and a net margin of 9.1%.
Valuation
- P/E23.1x
- P/E vs own-1.9%
- P/E vs sector-17.9%
- FCF yield+10.1%
- Market cap$18.12B
Quarterly results
Q2 FY2026: Revenue +4.8% year over year, free cash flow 15.2% of revenue, operating margin 15.0%.
RevenueFree cash flow
| Q2 FY2026 | Jun 30, 2026 | $2.18B | 1.03 | $331M | 70.8% | 15.0% | 9.1% |
| Q1 FY2026 | Mar 31, 2026 | $2.09B | 1.22 | $284M | 72.4% | 17.9% | 11.4% |
| Q4 FY2025 | Dec 31, 2025 | $2.24B | 0.70 | $669M | 64.7% | 12.8% | 6.2% |
| Q3 FY2025 | Sep 30, 2025 | $2B | 1.16 | $546M | 72.1% | 17.6% | 11.5% |
| Q2 FY2025 | Jun 30, 2025 | $2.08B | 0.77 | $298M | 71.5% | 14.4% | 7.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.91B | 0.91 | $336M | 71.2% | 15.3% | 9.5% |
| Q4 FY2024 | Dec 31, 2024 | $2.02B | 1.20 | $421M | 71.0% | 19.2% | 11.8% |
| Q3 FY2024 | Sep 30, 2024 | $1.82B | 1.23 | $369M | 70.5% | 15.3% | 13.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.94B | 1.18 | $223M | 71.5% | 18.1% | 12.5% |
| Q1 FY2024 | Mar 31, 2024 | $1.89B | 0.84 | $130M | 72.9% | 14.1% | 9.1% |
| Q4 FY2023 | Dec 31, 2023 | $1.94B | 2.01 | $526M | 72.2% | 18.3% | 21.6% |
| Q3 FY2023 | Sep 30, 2023 | $1.75B | 0.77 | $221M | 70.4% | 15.2% | 9.3% |